211 related articles for article (PubMed ID: 34766474)
21. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
22. Sarcoma-like tumor of head and neck skin.
Nonaka D; Bishop PW
Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
[TBL] [Abstract][Full Text] [Related]
23. Incidence rate and clinicopathological features of 62 atypical fibroxanthomas in a North-Western Spanish population.
Iglesias-Pena N; López-Solache L; Martínez-Campayo N; Meilán-Sánchez I; Yebra-Pimentel MT; Balboa-Barreiro V; Paradela S; Fonseca E
Australas J Dermatol; 2020 Feb; 61(1):e22-e27. PubMed ID: 31264202
[TBL] [Abstract][Full Text] [Related]
24. Pleomorphic dermal sarcoma: adverse histologic features predict aggressive behavior and allow distinction from atypical fibroxanthoma.
Miller K; Goodlad JR; Brenn T
Am J Surg Pathol; 2012 Sep; 36(9):1317-26. PubMed ID: 22510760
[TBL] [Abstract][Full Text] [Related]
25. Hydrochlorothiazide and increased risk of atypical fibroxanthoma and pleomorphic dermal sarcoma.
Kuntz T; Grimm A; Hofmann SC; Michalowitz AL; Schaller J; Hellmich M; Assaf C; Oellig F; Kreuter A
J Dtsch Dermatol Ges; 2024 Apr; 22(4):513-519. PubMed ID: 38483049
[TBL] [Abstract][Full Text] [Related]
26. Lymphovascular Invasion and High Mitotic Count Are Associated With Increased Risk of Recurrence in Pleomorphic Dermal Sarcoma.
Pons Benavent M; Ríos-Viñuela E; Nagore E; Monteagudo C; Aguerralde M; Mata Cano D; Llombart B; Serra-Guillén C; Pinazo Canales I; Requena C; Sanmartín O
Actas Dermosifiliogr; 2023; 114(7):572-579. PubMed ID: 37088288
[TBL] [Abstract][Full Text] [Related]
27. Atypical fibroxanthoma/pleomorphic dermal sarcoma of the scalp with aberrant expression of HMB-45: a pitfall in dermatopathology.
Piras V; Ferreli C; Atzori L; Pinna G; Pilloni L
Pathologica; 2020 Jun; 112(2):105-109. PubMed ID: 32760054
[TBL] [Abstract][Full Text] [Related]
28. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
29. Pleomorphic Dermal Sarcoma With Metastasis to the Lung: A Case Report.
Shafi S; Bechtel M; Contreras CM; Plaza JA
Am J Dermatopathol; 2023 Oct; 45(10):708-711. PubMed ID: 37335842
[TBL] [Abstract][Full Text] [Related]
30. Pleomorphic dermal sarcoma: a retrospective study of 16 cases in a dermato-oncology centre and a review of the literature.
Ríos-Viñuela E; Serra-Guillén C; Llombart B; Requena C; Nagore E; Traves V; Guillén C; Vázquez D; Sanmartín O
Eur J Dermatol; 2020 Oct; 30(5):545-553. PubMed ID: 33021478
[TBL] [Abstract][Full Text] [Related]
31. Atypical fibroxanthoma: An analysis of 105 tumors.
Bitel A; Schönlebe J; Krönert C; Wollina U
Dermatol Ther; 2020 Nov; 33(6):e13962. PubMed ID: 32618393
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta-analysis of individualized participant data.
Ørholt M; Aaberg FL; Abebe K; Walsh S; Roenigk RK; Venzo A; Schmidt G; Klyver H; Jensen DH; Herly M; Vester-Glowinski PV
J Surg Oncol; 2022 Sep; 126(3):555-562. PubMed ID: 35441377
[TBL] [Abstract][Full Text] [Related]
33. Hemato-Oncological Diseases as Risk Factor for Recurrence or Metastasis of Pleomorphic Dermal Sarcoma.
Helbig D
Front Oncol; 2022; 12():873771. PubMed ID: 35494063
[TBL] [Abstract][Full Text] [Related]
34. Undifferentiated pleomorphic sarcoma: Factors predictive of adverse outcomes.
Winchester D; Lehman J; Tello T; Chimato N; Hocker T; Kim S; Chang J; Markey J; Yom SS; Ryan W; Mully T; Hodge D; Otley C; Arron ST
J Am Acad Dermatol; 2018 Nov; 79(5):853-859. PubMed ID: 29787841
[TBL] [Abstract][Full Text] [Related]
35. Pleomorphic dermal sarcoma: a more aggressive neoplasm than previously estimated.
Tardío JC; Pinedo F; Aramburu JA; Suárez-Massa D; Pampín A; Requena L; Santonja C
J Cutan Pathol; 2016 Feb; 43(2):101-12. PubMed ID: 26264237
[TBL] [Abstract][Full Text] [Related]
36. Pleomorphic Dermal Sarcoma of the Scalp.
Klebanov N; Hoang MP; Reddy BY
Cureus; 2018 Jul; 10(7):e2979. PubMed ID: 30237940
[TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical Characteristics of Atypical Fibroxanthoma and Pleomorphic Dermal Sarcoma: A Systematic Review and Meta-Analysis.
Ørholt M; Abebe K; Aaberg F; Rasmussen LE; Daugaard S; Loya AC; Herly M; Vester-Glowinski PV
Am J Dermatopathol; 2022 Dec; 44(12):913-920. PubMed ID: 36395448
[TBL] [Abstract][Full Text] [Related]
38. Atypical fibroxanthoma and pleomorphic dermal sarcoma - gene expression analysis compared with undifferentiated cutaneous squamous cell carcinoma.
Anders IM; Schimmelpfennig C; Wiedemann K; Löffler D; Kämpf C; Blumert C; Reiche K; Kunz M; Anderegg U; Simon JC; Ziemer M
J Dtsch Dermatol Ges; 2023 May; 21(5):482-491. PubMed ID: 37035902
[TBL] [Abstract][Full Text] [Related]
39. Atypical fibroxanthoma and pleomorphic dermal sarcoma harbor frequent NOTCH1/2 and FAT1 mutations and similar DNA copy number alteration profiles.
Griewank KG; Wiesner T; Murali R; Pischler C; Müller H; Koelsche C; Möller I; Franklin C; Cosgarea I; Sucker A; Schadendorf D; Schaller J; Horn S; Brenn T; Mentzel T
Mod Pathol; 2018 Mar; 31(3):418-428. PubMed ID: 29099504
[TBL] [Abstract][Full Text] [Related]
40. Leiomyosarcoma and Pleomorphic Dermal Sarcoma: Guidelines for Diagnosis and Treatment.
Llombart B; Serra-Guillén C; Requena C; Alsina M; Morgado-Carrasco D; Machado I; Sanmartín O
Actas Dermosifiliogr (Engl Ed); 2019; 110(1):4-11. PubMed ID: 30409380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
